Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.
Melis GB, Paoletti AM, Bartolini R, Tosti Balducci M, Massi GB, Bruni V, Becorpi A, Ottanelli S, Fioretti P, Gambacciani M, et al.
Melis GB, et al. Among authors: gambacciani m.
Bone Miner. 1992 Oct;19 Suppl 1:S49-56. doi: 10.1016/0169-6009(92)90866-c.
Bone Miner. 1992.
PMID: 1422321
Clinical Trial.